Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
HUYABIO has entered into a clinical collaboration agreement with Bristol-Myers Squibb to evaluate the combination of HUYABIO's HBI-8000.
read more
Wednesday, February 25, 2015
Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the two companies will be rebranded to reflect the new integrated management structure that has been put in place and the broader product and service offerings of the combined...
read more
Thursday, February 20, 2020
Hummingbird Bioscience has signed an agreement with Mycenax Biotech for the production of material for the Phase 1 clinical trial of its HMBD-002 program.
read more
Monday, November 23, 2020
Humanigen announced the company and the DoD have entered into a CRADA in collaboration with the BARDA in support of Operation Warp Speed to assist in the development of lenzilumab as a potential COVID-19 treatment.
read more
Humanigen, Inc. announced it entered into an agreement with PCI Pharma Services (PCI), a integrated global contract development manufacturing organization (CDMO), to provide importation, release and commercialization services in the United Kingdom (...
read more
Thursday, August 20, 2020
Humanetics and Pii will work together to support a clinical trial of BIO 300 in COVID-19 patients.
read more
Hovione Technology has secured global rights to develop and commercialize a new ultra-affordable, multi-use blister-based dry powder inhaler patented by inventor Dr. Klaus-Dieter Beller.
read more
Tuesday, November 26, 2024
Hovione, announced completion of significant expansions in Europe and the USA. The investments at its East Windsor, New Jersey, and Ringaskiddy, Cork, facilities will significantly increase Hovione's global spray drying capacity and enhance the sites...
read more
Hovione today announced the appointment of Dr. Filipe Gaspar as Vice President of its Research and Development organization. Dr. Gaspar will lead teams based in Lisbon and New Jersey that serve our clients’ drug development projects; he will also be...
read more
Hovione today announced the appointment of Dr. Justin Hughey to lead the Particle Design sciences at our site in New Jersey. With over 30 publications, posters and book chapters Dr. Hughey is an acknowledged expert in the field of solubilization ...
read more
Hovione announced a new MG2 Tekna Precision Capsule filling unit is now online in its Portugal facilities.
read more
Wednesday, September 30, 2020
Hovione announced the signing of a partnership agreement with Ligand to ramp up the production output of Captisol.
read more
Wednesday, March 25, 2020
Hoth has reached an agreement with Voltron to form a joint venture entity to commence preclinical studies for the development of vaccine prospects to prevent, intercept or treat the COVID-19.
read more
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and...
read more
Wednesday, April 01, 2020
Horizon Discovery and Pharmahungary Group announced positive early-stage results for a novel micro-RNA therapeutic for ischemic heart diseases.
read more